Forefront Wealth Partners’s Pfizer PFE Stock Holding History

Forefront Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,830	Closed	-$327K	–	180
2025 Q3	$327K	Buy	+12,830	New	+$317K	0.08%	151

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Forefront Wealth Partners's PFE Position: Q4 2025 in Review

Forefront Wealth Partners sold out of Pfizer (PFE) in Q4 2025, closing a stake of 12,830 shares — an estimated $327K sold.

Forefront Wealth Partners first reported a position in PFE in Q3 2025 and held it in 1 quarter. The position peaked at $327K in Q3 2025. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Forefront Wealth Partners reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Forefront Wealth Partners sold 12,830 Pfizer shares in Q4 2025, an estimated $327K.
Forefront Wealth Partners first reported a position in Pfizer in Q3 2025 and held it in 1 quarter.
Forefront Wealth Partners's Pfizer position peaked at $327K in Q3 2025.
2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Forefront Wealth Partners's 13F filing for Q4 2025, filed 6 Feb 2026.